Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells
- 1 January 2003
- journal article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 3 (4) , 215-226
- https://doi.org/10.1038/sj.tpj.6500176
Abstract
The clinical efficacy of oral hydroxyurea (HU) in adults and children with sickle cell anemia (SCA) cannot solely be explained by its ability to enhance fetal hemoglobin (HbF) expression. Since increased adherence of sickle red blood cells to vascular endothelium is a possible contributing factor to vaso-occlusive crisis (VOC), we explored the effect of HU on human endothelial cell (EC) lines (TrHBMEC and EA-hy 926). We demonstrated that HU, in a dose-dependent and reversible manner, significantly decreased (up to three-fold) the release of endothelin-1 (ET-1), a vasoconstrictor peptide through downregulation (up to three-fold) of ET-1 gene expression. This finding is of therapeutic relevance as SCA patients exhibit elevated serum levels of ET-1 during episodes of VOC and levels correlate with disease severity. Unexpectedly, HU upregulated (up to three-fold) the expression of membrane-bound intercellular cell adhesion molecule 1 (mbICAM-1) and its soluble form (sICAM-1) with a parallel increase in ICAM-1 mRNA expression. Although ICAM-1 does not appear to be involved in the sickle cell adhesion to vascular endothelium, it may exacerbate vaso-occlusion by promoting leukocyte adhesion. The HU-induced increase in mbICAM-1 may appear inconsistent with the clinical benefits confered by HU. However, both the increase in sICAM-1- and HU-induced leukocyte reduction in patients, may counteract the potentially detrimental effect of elevated mbICAM-1 expression. Also HU reduces the expression of vascular cell adhesion molecule (VCAM-1) on EC. Since HU reduces the very late antigen 4-positive reticulocytes in SCA patients, a ligand for VCAM-1, HU-induced downregulation of VCAM-1 on EC will very likely decrease the reticulocyte-endothelium adhesion. Thus, HU, apart from inducing HbF expression in the red cell, also affects the expression profile of EC compartment.Keywords
This publication has 49 references indexed in Scilit:
- Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyureaBritish Journal of Haematology, 1999
- Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.Journal of Clinical Investigation, 1997
- Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture.Journal of Clinical Investigation, 1995
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- A Distinct mRNA Encoding a Soluble Form of ICAM-1 Molecule Expressed in Human TissuesCell Adhesion and Communication, 1995
- Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological SignificanceAnnals of the New York Academy of Sciences, 1992
- Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirusCell, 1992
- THE ROLE OF ENDOTHELIAL CELLS IN INFLAMMATIONTransplantation, 1990
- Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivoAmerican Journal of Hematology, 1989
- Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparumNature, 1989